Causeway Therapeutics

Causeway Therapeutics Overview

  • Founded
  • 2015
  • Status
  • Private
  • Latest Deal Type
  • Seed
  • Investors
  • 3

Causeway Therapeutics General Information


Provider of therapeutic services intended to offer treatment for tendon injury. The company's services are based on identifying the molecular mechanism that causes damaged tendons to develop tendinopathy caused by loss of microRNA and controls the repair process by their pharmaceutical product that mimics this natural microRNA and cures them, enabling patients to reduce the pain of damaged and weakened tendons at a faster and advanced way.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Primary Office
  • Number 11 The Square
  • University Avenue
  • Glasgow G12 8QQ
  • Scotland, United Kingdom

Causeway Therapeutics Timeline

Financing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Causeway Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 07-Feb-2019 00.00 Completed Startup
2. Grant 31-May-2018 00.000 00.00 Completed Generating Revenue
1. Seed Round 03-Aug-2017 $1.3M $1.3M 00.000 Completed Generating Revenue

Causeway Therapeutics Cap Table

To view Causeway Therapeutics‘s complete cap table, request access »
Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series Preferred 0,000 00.000000 0000.00 0000.00 00 0000.00 000

Causeway Therapeutics Executive Team (5)

Name Title Board Seat Contact Info
Derek Gilchrist Chief Executive Officer, Chief Scientific Officer & Co-Founder
David Armour Chief Financial Officer
Susan Kitson Chief Research Officer
Neal Millar Chief Medical Officer & Co-Founder
Declan Doogan MD Chairman

Causeway Therapeutics Board Members (4)

Name Representing Role Since
Christopher Jones Self Board Member 000 0000
Declan Doogan MD Self Chairman 000 0000
Neal Juster Ph.D Self Board Member 000 0000
Neil Gibson Causeway Therapeutics Board Member 000 0000

Causeway Therapeutics Investors (3)

To view Causeway Therapeutics‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Innovate UK Government 000 0000 000000 0
Mediqventures Venture Capital Minority 000 0000 000000 0
Scottish Enterprise Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial